PFR · Class II · 21 CFR 866.5900

FDA Product Code PFR: System, Cystic Fibrosis Transmembrane Conductance Regulator Gene, Mutations & Variants Panel Sequencing Detection

The Cftr Gene Mutation Detection System Is Used To Simultaneously Detect And Identify A Specified Panel Of Mutations And Variants In The Cftr Gene Using Sequencing Methods. It Is Intended For Carrier Screening, As An Aid In Confirmatory Diagnostic Testing Of Individuals With Suspected Cystic Fibrosis (cf), And As An Initial Test To Aid In The Diagnosis Of Individuals With Suspected Cf. It Is Not Intended For Stand-alone Diagnostic Purposes, Prenatal Diagnostic, Or Pre-implantation Screening.

1
Total
1
Cleared
328d
Avg days
2013
Since

FDA 510(k) Cleared System, Cystic Fibrosis Transmembrane Conductance Regulator Gene, Mutations & Variants Panel Sequencing Detection Devices (Product Code PFR)

1 devices
1–1 of 1
No devices found for this product code.

About Product Code PFR - Regulatory Context